ANDA 60624, held by Wyeth Ayerst. Ampicillin/Ampicillin Trihydrate.
As of Nov 16, 2026, ANDA 60624 (Omnipen (Ampicillin)), held by Wyeth Ayerst, was first approved by FDA on Dec 17, 1965, with 2 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 17, 1965 | Original application | Approved | None posted |
| Omnipen (Ampicillin)250MG · capsule;oral | Ampicillin/Ampicillin Trihydrate | Discontinued |
| Omnipen (Ampicillin)500MG · capsule;oral | Ampicillin/Ampicillin Trihydrate | Discontinued |
| Aug 13, 1996 | Supplement 2Manufacturing | Approved | None posted |
| Jun 30, 1993 | Supplement 1Labeling | Approved | None posted |
| Dec 17, 1965 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters